PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38 | -81.9% | 14,262 | -71.3% | 0.00% | -85.7% |
| Q4 2022 | $210 | -99.9% | 49,760 | +144.1% | 0.03% | +55.6% |
| Q2 2021 | $187,000 | +12.7% | 20,384 | +25.7% | 0.02% | 0.0% |
| Q4 2020 | $166,000 | +44.3% | 16,213 | +52.4% | 0.02% | +100.0% |
| Q3 2019 | $115,000 | -66.9% | 10,637 | -37.7% | 0.01% | -52.6% |
| Q4 2018 | $347,000 | -47.5% | 17,065 | +209.2% | 0.02% | -42.4% |
| Q3 2017 | $661,000 | – | 5,519 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |